COVID-19 (Coronavirus Disease 2019): A New Coronavirus Disease

References

• Kahn JS, McIntosh K. History and Recent Advances in Coronavirus Discovery. Pediatr Infect Dis J. 2005;24(11):S223–S227. doi:10.1097/01.inf.0000188166.17324.6016378050
   PubMedGoogle Scholar
• Tyrrell DAJ, Almeida JD, Cunningham CH, et al. Coronaviridae. Intervirology. 1975;5(1–2):76–82. doi:10.1159/0001498831184350
   PubMed Web of Science ®Google Scholar
• Fehr AR, Perlman S. Coronaviruses: an overview of their replication and pathogenesis. Methods Mol Biol. 2015;1282:1–23. doi:10.1007/978-1-4939-2438-7_125720466
   PubMedGoogle Scholar
• Gorbalenya AE, Baker SC, Baric RS, et al. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 2020;5(4):536–544. doi:10.1038/s41564-020-0695-z32123347
   PubMed Web of Science ®Google Scholar
• Fan Y, Zhao K, Shi Z, Zhou P. Bat Coronaviruses in China. Viruses. 2019;11(3):210. doi:10.3390/v11030210
   PubMed Web of Science ®Google Scholar
• Yin Y, Wunderink R. MERS, SARS and other coronaviruses as causes of pneumonia: MERS, SARS and coronaviruses. Respirology. 2017;23. doi:10.1111/resp.13196
   Web of Science ®Google Scholar
• Peiris JSM, Lai ST, Poon LLM, et al. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet. 2003;361(9366):1319–1325. doi:10.1016/S0140-6736(03)13077-212711465
   PubMed Web of Science ®Google Scholar
• Sexton NR, Smith EC, Blanc H, Vignuzzi M, Peersen OB, Denison MR. Homology-based identification of a mutation in the coronavirus RNA-Dependent RNA polymerase that confers resistance to multiple mutagens. J Virol. 2016;90(16):7415–7428. doi:10.1128/JVI.00080-1627279608
   PubMed Web of Science ®Google Scholar
• Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395(10224):565–574. doi:10.1016/S0140-6736(20)30251-832007145
   PubMed Web of Science ®Google Scholar
• Guo Y-R, Cao Q-D, Hong Z-S, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status. Mil Med Res. 2020;7(1):11. doi:10.1186/s40779-020-00240-032169119
   PubMed Web of Science ®Google Scholar
• Zhou P, Yang X-L, Wang X-G, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270–273. doi:10.1038/s41586-020-2012-732015507
   PubMed Web of Science ®Google Scholar
• Bárcena M, Oostergetel GT, Bartelink W, et al. Cryo-electron tomography of mouse hepatitis virus: insights into the structure of the coronavirion. Proc Natl Acad Sci U S A. 2009;106(2):582–587. doi:10.1073/pnas.080527010619124777
   PubMed Web of Science ®Google Scholar
• Brian DA, Baric RS. Coronavirus genome structure and replication. Curr Top Microbiol Immunol. 2005;287:1–30. doi:10.1007/3-540-26765-4_115609507
   PubMed Web of Science ®Google Scholar
• Tatar G, Taskin Tok T. Structures and Functions of Coronavirus Proteins: molecular Modeling of Viral Nucleoprotein. Int J Virol Infect Dis. 2017;2:1.
   Google Scholar
• Graham RL, Baric RS. Recombination, reservoirs, and the modular spike: mechanisms of coronavirus cross-species transmission. J Virol. 2010;84(7):3134–3146. doi:10.1128/JVI.01394-0919906932
   PubMed Web of Science ®Google Scholar
• Bosch BJ, van der Zee R, de Haan CAM, Rottier PJM. The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex. J Virol. 2003;77(16):8801–8811. doi:10.1128/jvi.77.16.8801-8811.200312885899
   PubMed Web of Science ®Google Scholar
• Collins AR, Knobler RL, Powell H, Buchmeier MJ. Monoclonal antibodies to murine hepatitis virus-4 (strain JHM) define the viral glycoprotein responsible for attachment and cell-cell fusion. Virology. 1982;119(2):358–371. doi:10.1016/0042-6822(82)90095-26281979
   PubMed Web of Science ®Google Scholar
• Ramadan N, Shaib H. Middle East respiratory syndrome coronavirus (MERS-CoV): A review. Germs. 2019;9(1):35–42. doi:10.18683/germs.2019.115531119115
   PubMedGoogle Scholar
• de Haan CA, Kuo L, Masters PS, Vennema H, Rottier PJ. Coronavirus particle assembly: primary structure requirements of the membrane protein. J Virol. 1998;72(8):6838–6850. doi:10.1128/JVI.72.8.6838-6850.19989658133
   PubMed Web of Science ®Google Scholar
• de Haan CAM, de Wit M, Kuo L, et al. The glycosylation status of the murine hepatitis coronavirus M protein affects the interferogenic capacity of the virus in vitro and its ability to replicate in the liver but not the brain. Virology. 2003;312(2):395–406. doi:10.1016/s0042-6822(03)00235-612919744
   PubMed Web of Science ®Google Scholar
• Hurst KR, Koetzner CA, Masters PS. Identification of in vivo-interacting domains of the murine coronavirus nucleocapsid protein. J Virol. 2009;83(14):7221–7234. doi:10.1128/JVI.00440-0919420077
   PubMed Web of Science ®Google Scholar
• Escors D, Ortego J, Laude H, Enjuanes L. The membrane M protein carboxy terminus binds to transmissible gastroenteritis coronavirus core and contributes to core stability. J Virol. 2001;75(3):1312–1324. doi:10.1128/JVI.75.3.1312-1324.200111152504
   PubMed Web of Science ®Google Scholar
• Raamsman MJ, Locker JK, de Hooge A, et al. Characterization of the coronavirus mouse hepatitis virus strain A59 small membrane protein E. J Virol. 2000;74(5):2333–2342. doi:10.1128/jvi.74.5.2333-2342.200010666264
   PubMed Web of Science ®Google Scholar
• Nieto-Torres JL, DeDiego ML, Verdiá-Báguena C, et al. Severe acute respiratory syndrome coronavirus envelope protein ion channel activity promotes virus fitness and pathogenesis. PLoS Pathog. 2014;10(5):e1004077. doi:10.1371/journal.ppat.100407724788150
   PubMed Web of Science ®Google Scholar
• Klausegger A, Strobl B, Regl G, Kaser A, Luytjes W, Vlasak R. Identification of a coronavirus hemagglutinin-esterase with a substrate specificity different from those of influenza C virus and bovine coronavirus. J Virol. 1999;73(5):3737–3743. doi:10.1128/JVI.73.5.3737-3743.199910196267
   PubMed Web of Science ®Google Scholar
• Cornelissen LA, Wierda CM, van der Meer FJ, et al. Hemagglutinin-esterase, a novel structural protein of torovirus. J Virol. 1997;71(7):5277–5286. doi:10.1128/JVI.71.7.5277-5286.19979188596
   PubMed Web of Science ®Google Scholar
• Malik YS, Sircar S, Bhat S, et al. Emerging novel coronavirus (2019-nCoV)—current scenario, evolutionary perspective based on genome analysis and recent developments. Vet Q. 2020;40(1):68–76. doi:10.1080/01652176.2020.172799332036774
   PubMed Web of Science ®Google Scholar
• Zhou P, Yang X-L, Wang X-G, et al. Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin. bioRxiv;2020.
   Google Scholar
• She J, Jiang J, Ye L, Hu L, Bai C, Song Y. 2019 novel coronavirus of pneumonia in Wuhan, China: emerging attack and management strategies. Clin Transl Med. 2020;9(1):19. doi:10.1186/s40169-020-00271-z32078069
   PubMed Web of Science ®Google Scholar
• Chan JF-W, Yuan S, Kok K-H, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395(10223):514–523. doi:10.1016/S0140-6736(20)30154-931986261
   PubMed Web of Science ®Google Scholar
• Jin Y-H, Cai L, Cheng Z-S, et al. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Mil Med Res. 2020;7(1):4. doi:10.1186/s40779-020-0233-632029004
   PubMed Web of Science ®Google Scholar
• Giovanetti M, Benvenuto D, Angeletti S, Ciccozzi M. The first two cases of 2019-nCoV in Italy: where they come from? J Med Virol. 2020;92(5):518–521. doi:10.1002/jmv.2569932022275
   PubMed Web of Science ®Google Scholar
• Paraskevis D, Kostaki EG, Magiorkinis G, Panayiotakopoulos G, Sourvinos G, Tsiodras S. Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event. Infect Genet Evol. 2020;79:104212. doi:10.1016/j.meegid.2020.10421232004758
   PubMed Web of Science ®Google Scholar
• Organization World Health.Coronavirus Disease (COVID-19) Outbreak Situation. WHO; 2020 https://www.who.int/emergencies/diseases/novel-coronavirus-2019.
   Google Scholar
• Lu C, Liu X, Jia Z. 2019-nCoV transmission through the ocular surface must not be ignored. Lancet. 2020:395. doi:10.1016/S0140-6736(20)30313-5
   Web of Science ®Google Scholar
• Phan LT, Nguyen TV, Luong QC, et al. Importation and Human-to-Human Transmission of a Novel Coronavirus in Vietnam. N Engl J Med. 2020;382(9):872–874. doi:10.1056/NEJMc200127231991079
   PubMed Web of Science ®Google Scholar
• Guan W, Ni Z, Hu Y, et al. Clinical characteristics of 2019 novel coronavirus infection in China. medRxiv. 2020:25458. doi:10.1101/2020.02.06.20020974
   Google Scholar
• Hoe GAN W, Wah LIM J, Koh D. Preventing intra-hospital infection and transmission of COVID-19 in healthcare workers. Saf Health Work. 2020. doi:10.1016/j.shaw.2020.03.001
   Web of Science ®Google Scholar
• Lai -C-C, Shih T-P, Ko W-C, Tang H-J, Hsueh P-R. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges. Int J Antimicrob Agents. 2020;55(3):105924. doi:10.1016/j.ijantimicag.2020.10592432081636
   PubMed Web of Science ®Google Scholar
• Ding S, Liang T. Is SARS-CoV-2 also an enteric pathogen with potential Fecal-Oral transmission: a COVID-19 virological and clinical review. Gastroenterology. 2020;159(1):53–61. doi:10.1053/j.gastro.2020.04.05232353371
   PubMed Web of Science ®Google Scholar
• Peng X, Xu X, Li Y, Cheng L, Zhou X, Ren B. Transmission routes of 2019-nCoV and controls in dental practice. Int J Oral Sci. 2020;12(1):9. doi:10.1038/s41368-020-0075-932127517
   PubMed Web of Science ®Google Scholar
• Zhou Z, Chen P, Peng H. Are healthy smokers really healthy? Tob Induc Dis. 2016;14(1). doi:10.1186/s12971-016-0101-z
   Web of Science ®Google Scholar
• Vardavas CI, Nikitara K. COVID-19 and smoking: A systematic review of the evidence. Tob Induc Dis. 2020;18(March). doi:10.18332/tid/119324
   Web of Science ®Google Scholar
• Teles Abrao Trad A, Ibirogba ER, Elrefaei A, et al. Complications and outcomes of SARS-CoV-2 in pregnancy: where and what is the evidence? Hypertens Pregnancy. 2020:1–9. doi:10.1080/10641955.2020.1769645.
   Web of Science ®Google Scholar
• Rasmussen SA, Smulian JC, Lednicky JA, Wen TS, Jamieson DJ. Coronavirus Disease 2019 (COVID-19) and Pregnancy: what obstetricians need to know. Am J Obstet Gynecol. 2020: doi:10.1016/j.ajog.2020.02.017
   Web of Science ®Google Scholar
• Karimi-Zarchi M, Neamatzadeh H, Dastgheib SA, et al. Vertical Transmission of Coronavirus Disease 19 (COVID-19) from infected pregnant mothers to neonates: a review. Fetal Pediatr Pathol. 2020:1–5. doi:10.1080/15513815.2020.1747120.
   Web of Science ®Google Scholar
• Wang S, Guo L, Chen L, et al. A case report of neonatal 2019 coronavirus disease in China. Clin Infect Dis. 2020. doi:10.1093/cid/ciaa225
   Web of Science ®Google Scholar
• Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia. N Engl J Med. 2020;382(13):1199–1207. doi:10.1056/NEJMoa200131631995857
   PubMed Web of Science ®Google Scholar
• Wang W, Tang J, Wei F. Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China. J Med Virol. 2020;92(4):441–447. doi:10.1002/jmv.2568931994742
   PubMed Web of Science ®Google Scholar
• Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. 2020;109:102433. doi:10.1016/j.jaut.2020.10243332113704
   PubMed Web of Science ®Google Scholar
• Wang Y, Kang H, Liu X, Tong Z. Combination of RT-qPCR testing and clinical features for diagnosis of COVID-19 facilitates management of SARS-CoV-2 outbreak. J Med Virol. 2020. doi:10.1002/jmv.25721
   Web of Science ®Google Scholar
• Lai -C-C, Liu YH, Wang C-Y, et al. Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): facts and myths. J Microbiol Immunol Infect. 2020;53(3):404–412. doi:10.1016/j.jmii.2020.02.01232173241
   PubMedGoogle Scholar
• Carlos WG, Dela Cruz CS, Cao B, Pasnick S, Jamil S. Novel Wuhan (2019-nCoV) Coronavirus. Am J Respir Crit Care Med. 2020;201(4):P7–P8. doi:10.1164/rccm.2014P732004066
   PubMed Web of Science ®Google Scholar
• Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi:10.1016/S0140-6736(20)30183-531986264
   PubMed Web of Science ®Google Scholar
• Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–1069. doi:10.1001/jama.2020.1585
   PubMed Web of Science ®Google Scholar
• Hassan SA, Sheikh FN, Jamal S, Ezeh JK, Akhtar A. Coronavirus (COVID-19): A Review of Clinical Features, Diagnosis, and Treatment. Cureus. 2020;12(3):e7355. doi:10.7759/cureus.735532328367
   PubMed Web of Science ®Google Scholar
• Adhikari SP, Meng S, Wu Y-J, et al. Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review. Infect Dis Poverty. 2020;9(1):29. doi:10.1186/s40249-020-00646-x32183901
   PubMed Web of Science ®Google Scholar
• Deeks JJ, Dinnes J, Takwoingi Y, et al. Diagnosis of SARS‐CoV‐2 infection and COVID‐19: accuracy of signs and symptoms; molecular, antigen, and antibody tests; and routine laboratory markers. Cochrane Database Syst Rev. 2020;4.
   Google Scholar
• Wilder-Smith A, Low J. Risk of respiratory infections in health care workers: lessons on infection control emerge from the SARS outbreak. Southeast Asian J Trop Med Public Health. 2005;36(2):481–488.15916060
   PubMedGoogle Scholar
• Ai T, Yang Z, Hou H, et al. Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases. Radiology. 2020:200642. doi:10.1148/radiol.2020200642.
   PubMed Web of Science ®Google Scholar
• Mahdavi A, Khalili N, Davarpanah AH, et al. Radiologic Management of COVID-19: preliminary Experience of the Iranian Society of Radiology COVID-19 Consultant Group (ISRCC). Iran J Radiol. 2020:e102324; doi:10.5812/iranjradiol.102324
   Web of Science ®Google Scholar
• Karimi A, Rajabnejad SRTM, Rahimi ZPH, et al. An Algorithmic Approach to Diagnosis and Treatment of Coronavirus Disease 2019 (COVID-19) in Children: iranian Expert’s Consensus Statement. Arch Pediatr Infect Dis. 2020;8(2):e102400. doi:10.5812/pedinfect.102400
   Web of Science ®Google Scholar
• Bradley JS, Byington CL, Shah SS, et al. The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the pediatric infectious diseases society and the infectious diseases society of America. Clin Infect Dis. 2011;53(7):e25–e76. doi:10.1093/cid/cir53121880587
   PubMed Web of Science ®Google Scholar
• Tang Y-W, Schmitz JE, Persing DH, Stratton CW. Laboratory Diagnosis of COVID-19: current Issues and Challenges. McAdam AJ, ed. J Clin Microbiol. 2020;58(6):e00512–200520. doi:10.1128/JCM.00512-2032245835
   PubMed Web of Science ®Google Scholar
• Li X, Geng M, Peng Y, Meng L, Lu S. Molecular immune pathogenesis and diagnosis of COVID-19. J Pharm Anal. 2020;10(2):102–108. doi:10.1016/j.jpha.2020.03.00132282863
   PubMed Web of Science ®Google Scholar
• Yang T, Wang Y-C, Shen C-F, Cheng C-M. Point-of-Care RNA-Based Diagnostic Device for COVID-19. Diagnostics. 2020;10(3):165. doi:10.3390/diagnostics10030165
   Web of Science ®Google Scholar
• Corman VM, Landt O, Kaiser M, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 2020;25(3):2000045. doi:10.2807/1560-7917.ES.2020.25.3.2000045
   PubMedGoogle Scholar
• Zhang L, Liu Y. Potential interventions for novel coronavirus in China: A systematic review. J Med Virol. 2020;92(5):479–490. doi:10.1002/jmv.2570732052466
   PubMed Web of Science ®Google Scholar
• Holshue ML, DeBolt C, Lindquist S, et al. First Case of 2019 Novel Coronavirus in the United States. N Engl J Med. 2020;382(10):929–936. doi:10.1056/NEJMoa200119132004427
   PubMed Web of Science ®Google Scholar
• De Clercq E. New nucleoside analogues for the treatment of hemorrhagic fever virus infections. Chem an Asian J. 2019;14(22):3962–3968. doi:10.1002/asia.201900841
   PubMed Web of Science ®Google Scholar
• Zumla A, Chan JFW, Azhar EI, Hui DSC, Yuen K-Y. Coronaviruses - drug discovery and therapeutic options. Nat Rev Drug Discov. 2016;15(5):327–347. doi:10.1038/nrd.2015.3726868298
   PubMed Web of Science ®Google Scholar
• Toots M, Yoon -J-J, Cox RM, et al. Characterization of orally efficacious influenza drug with high resistance barrier in ferrets and human airway epithelia. Sci Transl Med. 2019;11(515):eaax5866. doi:10.1126/scitranslmed.aax586631645453
   PubMed Web of Science ®Google Scholar
• Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–513. doi:10.1016/S0140-6736(20)30211-732007143
   PubMed Web of Science ®Google Scholar
• Gao J, Tian Z, Yang X. Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci Trends. 2020;14(1):72–73. doi:10.5582/bst.2020.0104732074550
   PubMed Web of Science ®Google Scholar
• Wang M, Cao R, Zhang L, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020;30(3):269–271. doi:10.1038/s41422-020-0282-032020029
   PubMed Web of Science ®Google Scholar
• Li W. [The curative effect observation of shuanghuanglian and penicillin on acute tonsillitis]. Lin Chuang Er Bi Yan Hou Ke Za Zhi. 2002;16:475–476. Chinese.15515537
   PubMedGoogle Scholar
• Chen X, Howard OM, Yang X, Wang L, Oppenheim J, Krakauer T. Effects of Shuanghuanglian and Qingkailing, two multi-components of traditional Chinese medicinal preparations, on human leukocyte function. Life Sci. 2002;70(24):2897–2913. doi:10.1016/S0024-3205(02)01541-212269401
   PubMed Web of Science ®Google Scholar
• Lu HT, Yang JC, Yuan ZC, Sheng WH, Yan WH. [Effect of combined treatment of Shuanghuanglian and recombinant interferon alpha 2a on coxsackievirus B3 replication in vitro]. Zhongguo Zhong Yao Za Zhi. 2000;25(11):682–684.Chinese.12525074
   PubMedGoogle Scholar
• Ding Y, Zeng L, Li R, et al. The Chinese prescription lianhuaqingwen capsule exerts anti-influenza activity through the inhibition of viral propagation and impacts immune function. BMC Complement Altern Med. 2017;17(1):130. doi:10.1186/s12906-017-1585-728235408
   PubMed Web of Science ®Google Scholar
• Jo S, Kim S, Shin DH, Kim M-S. Inhibition of SARS-CoV 3CL protease by flavonoids. J Enzyme Inhib Med Chem. 2020;35(1):145–151. doi:10.1080/14756366.2019.169048031724441
   PubMed Web of Science ®Google Scholar
• Chen L, Gui C, Luo X, et al. Cinanserin Is an Inhibitor of the 3C-like proteinase of severe acute respiratory syndrome coronavirus and strongly reduces virus replication in vitro. J Virol. 2005;79(11):7095–7103. doi:10.1128/JVI.79.11.7095-7103.200515890949
   PubMed Web of Science ®Google Scholar
• Wang L, Wang Y, Ye D, Liu Q. A review of the 2019 Novel Coronavirus (COVID-19) based on current evidence. Int J Antimicrob Agents. 2020;55(6):105948. doi:10.1016/j.ijantimicag.2020.10594832201353
   PubMed Web of Science ®Google Scholar
• Mustafa S, Balkhy H, Gabere MN. Current treatment options and the role of peptides as potential therapeutic components for Middle East Respiratory Syndrome (MERS): A review. J Infect Public Health. 2018;11(1):9–17. doi:10.1016/j.jiph.2017.08.00928864360
   PubMed Web of Science ®Google Scholar
• Gilardin L, Bayry J, Kaveri SV. Intravenous immunoglobulin as clinical immune-modulating therapy. CMAJ. 2015;187(4):257–264. doi:10.1503/cmaj.13037525667260
   PubMed Web of Science ®Google Scholar
• Kumar V, Jung Y-S, Liang P-H. Anti-SARS coronavirus agents: a patent review (2008 – present). Expert Opin Ther Pat. 2013;23(10):1337–1348. doi:10.1517/13543776.2013.82315923905913
   PubMed Web of Science ®Google Scholar
• Chen C, Qi F, Shi K, et al. Thalidomide combined with low-dose glucocorticoid in the treatment of COVID-19 pneumonia. 2020.
   Google Scholar
• Mair-Jenkins J, Saavedra-Campos M, Baillie JK, et al. The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis. J Infect Dis. 2015;211(1):80–90. doi:10.1093/infdis/jiu39625030060
   PubMed Web of Science ®Google Scholar
• Soo YOY, Cheng Y, Wong R, et al. Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients. Clin Microbiol Infect. 2004;10(7):676–678. doi:10.1111/j.1469-0691.2004.00956.x15214887
   PubMed Web of Science ®Google Scholar
• Hung IFN, To KKW, Lee C-K, et al. Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 Virus Infection. Clin Infect Dis. 2011;52(4):447–456. doi:10.1093/cid/ciq10621248066
   PubMed Web of Science ®Google Scholar
• Monteil V, Kwon H, Prado P, Hagelkrüys A, Wimmer RA. Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2. Cell Press. 2020. doi:10.1016/j.cell.2020.04.004
   Google Scholar
• Zarbock A, Kellum JA, Schmidt C, et al. Effect of early vs delayed initiation of renal replacement therapy on mortality in critically ill patients with acute kidney injury: the ELAIN randomized clinical trial. J Am Med Assoc. 2016;315(20):2190–2199. doi:10.1001/jama.2016.5828
   PubMed Web of Science ®Google Scholar
• Vetter P, Eckerle I, Kaiser L. Covid-19: a puzzle with many missing pieces. BMJ. 2020;368:m627. doi:10.1136/bmj.m62732075791
   PubMed Web of Science ®Google Scholar
• Luo H, Tang Q, Shang Y, et al. Can Chinese medicine be used for prevention of corona virus disease 2019 (COVID-19)? A review of historical classics, research evidence and current prevention programs. Chin J Integr Med. 2020;26(4):243–250. doi:10.1007/s11655-020-3192-632065348
   PubMed Web of Science ®Google Scholar
• Nonnecke BJ, McGill JL, Ridpath JF, Sacco RE, Lippolis JD, Reinhardt TA. Acute phase response elicited by experimental bovine diarrhea virus (BVDV) infection is associated with decreased vitamin D and E status of vitamin-replete preruminant calves1. J Dairy Sci. 2014;97(9):5566–5579. doi:10.3168/jds.2014-829325022687
   PubMed Web of Science ®Google Scholar
• Liang W, Guan W, Chen R, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21(3):335–337. doi:10.1016/S1470-2045(20)30096-632066541
   PubMed Web of Science ®Google Scholar
• High KP. Nutritional Strategies to Boost Immunity and Prevent Infection in Elderly Individuals. Clin Infect Dis. 2001;33(11):1892–1900. doi:10.1086/32450911692301
   PubMed Web of Science ®Google Scholar
• Abdi M. Coronavirus disease 2019 (COVID-19) outbreak in Iran; actions and problems. Infect Control Hosp Epidemiol. 2020;1–5.
   Web of Science ®Google Scholar